{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:51:08Z","timestamp":1793299868297,"version":"4.5.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T00:00:00Z","timestamp":1764374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-25631-7","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T03:36:19Z","timestamp":1764387379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Barriers to and enablers of adherence to the treatment of active drug-sensitive tuberculosis in people living with HIV: a mixed method systematic review"],"prefix":"10.1186","volume":"26","author":[{"given":"AbdulAzeez","family":"Lawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abimbola","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Tiberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinke","family":"Kunst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,29]]},"reference":[{"key":"25631_CR1","unstructured":"World Health Organization (WHO). Global tuberculosis report 2024. https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/"},{"issue":"1","key":"25631_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S2213-2600(17)30468-X","volume":"6","author":"TK Burki","year":"2018","unstructured":"Burki TK. The global cost of tuberculosis. Lancet Respir Med. 2018;6(1):13.","journal-title":"Lancet Respir Med"},{"key":"25631_CR3","doi-asserted-by":"publisher","unstructured":"Bruchfeld J, Correia-Neves M, Kallenius G. Tuberculosis and HIV coinfection. Cold Spring Harb Perspect Med. 2015;5(7):a017871. https:\/\/doi.org\/10.1101\/cshperspect.a017871.","DOI":"10.1101\/cshperspect.a017871"},{"key":"25631_CR4","unstructured":"World Health Organization (WHO). Adherence To Long-term Therapies: Evidence for action. https:\/\/www.who.int\/chp\/knowledge\/publications\/adherence_full_report.pdf?ua=1. Accessed 23 Jan 2023."},{"key":"25631_CR5","unstructured":"World Health Organization. What is DOTS? A Guide to Understanding the WHO-recommended TB Control Strategy Known as DOTS. https:\/\/iris.who.int\/bitstream\/handle\/10665\/65979\/WHO_CDS_CPC_TB_99.270.pdf"},{"key":"25631_CR6","doi-asserted-by":"publisher","unstructured":"Karumbi J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Reviews. 2015;2015(5). https:\/\/doi.org\/10.1002\/14651858.CD003343.pub4.","DOI":"10.1002\/14651858.CD003343.pub4"},{"issue":"1","key":"25631_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-016-1862-y","volume":"16","author":"ZM McLaren","year":"2016","unstructured":"McLaren ZM, Milliken AA, Meyer AJ, Sharp AR. Does directly observed therapy improve tuberculosis treatment? More evidence is needed to guide tuberculosis policy. BMC Infect Dis. 2016;16(1):1\u20134. https:\/\/doi.org\/10.1186\/s12879-016-1862-y.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"25631_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/00187259.2023.2286173","volume":"83","author":"J Stillo","year":"2024","unstructured":"Stillo J. Connecting the DOTS: should we still be doing directly observed therapy? Hum Organ. 2024;83(1):18\u201330. https:\/\/doi.org\/10.1080\/00187259.2023.2286173.","journal-title":"Hum Organ"},{"key":"25631_CR9","doi-asserted-by":"publisher","unstructured":"Moomba K, Van Wyk B. Social and economic barriers to adherence among patients at Livingstone general hospital in Zambia. Afr J Prim Health Care Fam Med. 2019;11(1). https:\/\/doi.org\/10.4102\/phcfm.v11i1.1740.","DOI":"10.4102\/phcfm.v11i1.1740"},{"issue":"1","key":"25631_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13643-019-1014-8","volume":"8","author":"A Gast","year":"2019","unstructured":"Gast A, Mathes T. Medication adherence influencing factors\u2014an (updated) overview of systematic reviews. Syst Rev. 2019;8(1):112. https:\/\/doi.org\/10.1186\/s13643-019-1014-8.","journal-title":"Syst Rev"},{"issue":"9","key":"25631_CR11","doi-asserted-by":"publisher","first-page":"e072358","DOI":"10.1136\/bmjopen-2023-072358","volume":"13","author":"P Gala","year":"2023","unstructured":"Gala P, Kamano JH, Vazquez Sanchez M, Mugo R, Orango V, Pastakia S, et al. Cross-sectional analysis of factors associated with medication adherence in Western Kenya. BMJ Open. 2023;13(9):e072358. https:\/\/doi.org\/10.1136\/bmjopen-2023-072358.","journal-title":"BMJ Open"},{"issue":"1","key":"25631_CR12","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s41043-023-00459-2","volume":"42","author":"CM Studer","year":"2023","unstructured":"Studer CM, Linder M, Pazzagli L. A global systematic overview of socioeconomic factors associated with antidiabetic medication adherence in individuals with type 2 diabetes. J Health Popul Nutr. 2023;42(1):122. https:\/\/doi.org\/10.1186\/s41043-023-00459-2.","journal-title":"J Health Popul Nutr"},{"issue":"1","key":"25631_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41043-017-0132-y","volume":"37","author":"FH Gebreweld","year":"2018","unstructured":"Gebreweld FH, Kifle MM, Gebremicheal FE, Simel LL, Gezae MM, Ghebreyesus SS, et al. Factors influencing adherence to tuberculosis treatment in Asmara, Eritrea: a qualitative study. J Health Popul Nutr. 2018;37(1):1\u20139. https:\/\/doi.org\/10.1186\/s41043-017-0132-y.","journal-title":"J Health Popul Nutr"},{"issue":"10","key":"25631_CR14","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1111\/tmi.12365","volume":"19","author":"S Laokri","year":"2014","unstructured":"Laokri S, Dramaix-Wilmet M, Kassa F, Anagonou S, Dujardin B. Assessing the economic burden of illness for tuberculosis patients in Benin: determinants and consequences of catastrophic health expenditures and inequities. Trop Med Int Health. 2014;19(10):1249\u201358. https:\/\/doi.org\/10.1111\/tmi.12365.","journal-title":"Trop Med Int Health"},{"key":"25631_CR15","doi-asserted-by":"publisher","DOI":"10.5402\/2013\/461704","author":"YB Jibrin","year":"2013","unstructured":"Jibrin YB, Ali AB, Saad ST, Kolo PM. Clinical study prevalence of treatment failure among pulmonary tuberculosis patients in federal medical Centre, Gombe, Northeastern Nigeria. ISRN Infect Dis. 2013. https:\/\/doi.org\/10.5402\/2013\/461704.","journal-title":"ISRN Infect Dis"},{"issue":"4","key":"25631_CR16","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.4025\/cienccuidsaude.v14i4.25093","volume":"14","author":"NH Orf\u00e3o","year":"2016","unstructured":"Orf\u00e3o NH, Andrade RL, de Beraldo P, Brunello AA, Scatena MEF, Villa LM. Ades\u00e3o terap\u00eautica Ao Tratamento Da tuberculose Em Um munic\u00edpio do Estado de S\u00e3o Paulo\/ adherence therapeutic to the treatment of tuberculosis in a municipality of the S\u00e3o Paulo state. Ci\u00eancia Cuidado E Sa\u00fade. 2016;14(4):1453.","journal-title":"Ci\u00eancia Cuidado E Sa\u00fade"},{"key":"25631_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab190","author":"R Subbaraman","year":"2021","unstructured":"Subbaraman R, Thomas BE, Vignesh Kumar J, Thiruvengadam K, Khandewale A, Kokila S, et al. Understanding nonadherence to tuberculosis medications in India using urine drug metabolite testing: a cohort study. Open Forum Infect Dis. 2021. https:\/\/doi.org\/10.1093\/ofid\/ofab190.","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"25631_CR18","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12879-020-4865-7","volume":"20","author":"LNQ Vo","year":"2020","unstructured":"Vo LNQ, Codlin AJ, Forse RJ, Nguyen HT, Vu TN, Van Truong V, et al. Tuberculosis among economic migrants: a cross-sectional study of the risk of poor treatment outcomes and impact of a treatment adherence intervention among temporary residents in an urban district in Ho Chi Minh City, Viet Nam. BMC Infect Dis. 2020;20(1):134. https:\/\/doi.org\/10.1186\/s12879-020-4865-7.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"25631_CR19","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3855\/jidc.12029","volume":"14","author":"S Khunthason","year":"2020","unstructured":"Khunthason S, Kaewkungwal J, Pan-Ngum W, Okascharoen C, Apidechkul T, Lawpoolsri S. The factors associated with the unsuccessful tuberculosis treatment of hill tribe patients in Thailand. J Infect Dev Ctries. 2020;14(1):42\u20137. https:\/\/doi.org\/10.3855\/jidc.12029.","journal-title":"J Infect Dev Ctries"},{"issue":"9","key":"25631_CR20","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.5588\/ijtld.14.0670","volume":"19","author":"J Sitienei","year":"2015","unstructured":"Sitienei J, Kipruto H, Mansour O, Ndisha M, Hanson C, Wambu R, et al. Correlates of default from anti-tuberculosis treatment: a case study using kenya\u2019s electronic data system. Int J Tuberc Lung Dis. 2015;19(9):1051\u20136. https:\/\/doi.org\/10.5588\/ijtld.14.0670.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"25631_CR21","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1590\/S0080-62342010000400041","volume":"44","author":"LA de Souza Neves","year":"2010","unstructured":"de Souza Neves LA, Reis RK, Gir E. Adherence to treatment by individuals with HIV \/ tuberculosis co-infection: an integrative literature review. Revista Da Escola De Enfermagem. 2010;44(4):1135\u201341.","journal-title":"Revista Da Escola De Enfermagem"},{"key":"25631_CR22","doi-asserted-by":"crossref","unstructured":"Lutge EE, Wiysonge CS, Knight SE, Sinclair D, Volmink J. Incentives and enablers to improve adherence in tuberculosis. Cochrane Database of Systematic Reviews. 2015;2015;9. https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD007952.pub3\/full","DOI":"10.1002\/14651858.CD007952.pub3"},{"issue":"1","key":"25631_CR23","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijnurstu.2011.07.002","volume":"49","author":"R Pace","year":"2012","unstructured":"Pace R, Pluye P, Bartlett G, Macaulay AC, Salsberg J, Jagosh J, et al. Testing the reliability and efficiency of the pilot mixed methods appraisal tool (MMAT) for systematic mixed studies review. Int J Nurs Stud. 2012;49(1):47\u201353. https:\/\/doi.org\/10.1016\/j.ijnurstu.2011.07.002.","journal-title":"Int J Nurs Stud"},{"key":"25631_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2019-002280","volume":"5","author":"C Oga-Omenka","year":"2020","unstructured":"Oga-Omenka C, Tseja-Akinrin A, Sen P, Mac-Seing M, Agbaje A, Menzies D, et al. Factors influencing diagnosis and treatment initiation for multidrug-resistant\/rifampicin-resistant tuberculosis in six sub-Saharan African countries: a mixed-methods systematic review. BMJ Glob Health. 2020;5:e022807. https:\/\/doi.org\/10.1136\/bmjgh-2019-002280.","journal-title":"BMJ Glob Health"},{"key":"25631_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-017-3964-5","author":"BK Clifford","year":"2018","unstructured":"Clifford BK, Mizrahi D, Sandler CX, Barry BK, Simar D, Wakefield CE, et al. Barriers and facilitators of exercise experienced by cancer survivors: a mixed methods systematic review. Support Care Cancer. 2018. https:\/\/doi.org\/10.1007\/s00520-017-3964-5.","journal-title":"Support Care Cancer"},{"key":"25631_CR26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2648.2005.03621.x","author":"R Whittemore","year":"2005","unstructured":"Whittemore R, Knafl K. The integrative review: updated methodology. J Adv Nurs. 2005. https:\/\/doi.org\/10.1111\/j.1365-2648.2005.03621.x. https:\/\/onlinelibrary.wiley.com\/doi\/full\/.","journal-title":"J Adv Nurs"},{"key":"25631_CR27","unstructured":"UCLA Institute for Digital Research and Education. Logistic Regression | SPSS Annotated Output. https:\/\/stats.idre.ucla.edu\/spss\/output\/logistic-regression\/"},{"issue":"1","key":"25631_CR28","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/1471-2458-13-396","volume":"13","author":"P Naidoo","year":"2013","unstructured":"Naidoo P, Peltzer K, Louw J, Matseke G, McHunu G, Tutshana B. Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South africa: a cross sectional study. BMC Public Health. 2013;13(1):396. https:\/\/doi.org\/10.1186\/1471-2458-13-396.","journal-title":"BMC Public Health"},{"issue":"3","key":"25631_CR29","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.jmii.2013.05.001","volume":"47","author":"ZC M\u00e9da","year":"2014","unstructured":"M\u00e9da ZC, Lin YT, Sombi\u00e9 I, Mar\u00e9 D, Morisky DE, Chen YMA. Medication-adherence predictors among patients with tuberculosis or human immunodeficiency virus infection in Burkina Faso. J Microbiol Immunol Infect. 2014;47(3):222\u201332. https:\/\/doi.org\/10.1016\/j.jmii.2013.05.001.","journal-title":"J Microbiol Immunol Infect"},{"issue":"11","key":"25631_CR30","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.5588\/ijtld.10.0273","volume":"15","author":"AM Kipp","year":"2011","unstructured":"Kipp AM, Pungrassami P, Stewart PW, Chongsuvivatwong V, Strauss RP, Van Rie A. Study of tuberculosis and AIDS stigma as barriers to tuberculosis treatment adherence using validated stigma scales. Int J Tuberculosis Lung Disease. 2011;15(11):1540\u20135. https:\/\/doi.org\/10.5588\/ijtld.10.0273.","journal-title":"Int J Tuberculosis Lung Disease"},{"key":"25631_CR31","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https:\/\/doi.org\/10.1136\/bmj.n71.","journal-title":"BMJ"},{"key":"25631_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0159317","author":"EW Mazinyo","year":"2016","unstructured":"Mazinyo EW, Kim L, Masuku S, Lancaster JL, Odendaal R, Uys M, et al. Adherence to concurrent tuberculosis treatment and antiretroviral treatment among co-infected persons in South Africa, 2008\u20132010. PLoS ONE. 2016. https:\/\/doi.org\/10.1371\/journal.pone.0159317. 11;7.","journal-title":"PLoS ONE"},{"key":"25631_CR33","doi-asserted-by":"publisher","unstructured":"Knight M, Van Zyl RL, Sanne I, Bassett J, Van Rie A. Impact of combination antiretroviral therapy initiation on adherence to antituberculosis treatment. South Afr J HIV Med. 2015;16(1). https:\/\/doi.org\/10.4102\/sajhivmed.v16i1.346.","DOI":"10.4102\/sajhivmed.v16i1.346"},{"issue":"6","key":"25631_CR34","doi-asserted-by":"publisher","first-page":"e37634","DOI":"10.1371\/journal.pone.0037634","volume":"7","author":"DJ Pepper","year":"2012","unstructured":"Pepper DJ, Marais S, Bhaijee F, Wilkinson RJ, De Azevedo V, Meintjes G. Assessment at antiretroviral clinics during TB treatment reduces loss to follow-up among HIV-infected patients. PLoS ONE. 2012;7(6):e37634. https:\/\/doi.org\/10.1371\/journal.pone.0037634.","journal-title":"PLoS ONE"},{"issue":"1","key":"25631_CR35","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1186\/1471-2458-10-651","volume":"10","author":"MK Gebremariam","year":"2010","unstructured":"Gebremariam MK, Bjune GA, Frich JC. Barriers and facilitators of adherence to TB treatment in patients on concomitant TB and HIV treatment: A qualitative study. BMC Public Health. 2010;10(1):651. https:\/\/doi.org\/10.1186\/1471-2458-10-651. https:\/\/bmcpublichealth.biomedcentral.com\/articles\/.","journal-title":"BMC Public Health"},{"issue":"2","key":"25631_CR36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.4103\/1947-2714.93376","volume":"4","author":"A Kebede","year":"2012","unstructured":"Kebede A, Wabe NT. Medication adherence and its determinants among patients on concomitant tuberculosis and antiretroviral therapy in South West Ethiopia. N Am J Med Sci. 2012;4(2):67\u201371. https:\/\/doi.org\/10.4103\/1947-2714.93376.","journal-title":"N Am J Med Sci"},{"issue":"5","key":"25631_CR37","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s10900-009-9215-z","volume":"35","author":"P Sardar","year":"2010","unstructured":"Sardar P, Jha A, Roy D, Roy S, Guha P, Bandyopadhyay D. Intensive phase non-compliance to anti tubercular treatment in patients with HIV-TB coinfection: a hospital-based cross-sectional study. J Community Health. 2010;35(5):471\u20138. https:\/\/doi.org\/10.1007\/s10900-009-9215-z.","journal-title":"J Community Health"},{"issue":"2","key":"25631_CR38","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4103\/0970-0218.177529","volume":"41","author":"SBR Satti","year":"2016","unstructured":"Satti SBR, Kondagunta N. Risk factors for Dots treatment default among new HIV-TB coinfected patients in Nalgonda (Dist.) Telangana (State): a case control study. Indian J Community Med. 2016;41(2):120\u20135. https:\/\/doi.org\/10.4103\/0970-0218.177529.","journal-title":"Indian J Community Med"},{"issue":"1","key":"25631_CR39","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/1471-2334-11-351","volume":"11","author":"M Maruza","year":"2011","unstructured":"Maruza M, Milit\u00e3o Albuquerque MFP, Coimbra I, Moura LV, Montarroyos UR, Miranda Filho DB, et al. Risk factors for default from tuberculosis treatment in HIV-infected individuals in the state of Pernambuco, brazil: A prospective cohort study. BMC Infect Dis. 2011;11(1):351. https:\/\/doi.org\/10.1186\/1471-2334-11-351.","journal-title":"BMC Infect Dis"},{"key":"25631_CR40","doi-asserted-by":"crossref","unstructured":"Dam\u00e1sio1 GS. Martins Fran\u00e7a, Rayana A. De Ara\u00fajo1A, Feij\u00e3o1AR. Social, clinical, and adherence factors in patients co-infected with HIV\/ Tuberculosis: a descriptive study. Online Braz J Nurs. 2016;15(3):414\u201322.","DOI":"10.17665\/1676-4285.20165397"},{"issue":"8","key":"25631_CR41","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1111\/j.1365-3156.2011.02800.x","volume":"16","author":"S Elbireer","year":"2011","unstructured":"Elbireer S, Guwatudde D, Mudiope P, Nabbuye-Sekandi J, Manabe YC. Tuberculosis treatment default among HIV-TB co-infected patients in urban Uganda. Trop Med Int Health. 2011;16(8):981\u20137. https:\/\/doi.org\/10.1111\/j.1365-3156.2011.02800.x.","journal-title":"Trop Med Int Health"},{"key":"25631_CR42","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.2147\/PPA.S135540","volume":"11","author":"S Hermans","year":"2017","unstructured":"Hermans S, Elbireer S, Tibakabikoba H, Hoefman B, Manabe Y. Text messaging to decrease tuberculosis treatment attrition in TB-HIV coinfection in Uganda. Patient Prefer Adherence. 2017;11:1479\u201387. https:\/\/doi.org\/10.2147\/PPA.S135540.","journal-title":"Patient Prefer Adherence"},{"issue":"2","key":"25631_CR43","doi-asserted-by":"publisher","first-page":"34","DOI":"10.31838\/ijprt\/10.02.05","volume":"10","author":"BO Ukoha-Kalu","year":"2020","unstructured":"Ukoha-Kalu BO, Adibe MO. Determinants of medication adherence among patients on concomitant tuberculosis and antiretroviral therapy in Kogi state Nigeria. Int J Pharm Res Technol. 2020;10(2):34\u201340. https:\/\/doi.org\/10.31838\/ijprt\/10.02.05.","journal-title":"Int J Pharm Res Technol"},{"issue":"11","key":"25631_CR44","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1089\/apc.2011.0304","volume":"26","author":"BA Ushie","year":"2012","unstructured":"Ushie BA, Jegede AS. The paradox of family support: concerns of Tuberculosis-infected HIV patients about involving family and friends in their treatment. AIDS Patient Care STDS. 2012;26(11):674\u201380. https:\/\/doi.org\/10.1089\/apc.2011.0304.","journal-title":"AIDS Patient Care STDS"},{"key":"25631_CR45","doi-asserted-by":"publisher","DOI":"10.1177\/2050312121989497","volume":"9","author":"CN Iweama","year":"2021","unstructured":"Iweama CN, Agbaje OS, Umoke PCI, Igbokwe CC, Ozoemena EL, Omaka-Amari NL, et al. Nonadherence to tuberculosis treatment and associated factors among patients using directly observed treatment short-course in north-west nigeria: a cross-sectional study. SAGE Open Med. 2021;9:2050312121989497. https:\/\/doi.org\/10.1177\/2050312121989497.","journal-title":"SAGE Open Med"},{"issue":"Suppl 1","key":"25631_CR46","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1097\/QAI.0000000000001202","volume":"74","author":"Y Hirsch-Moverman","year":"2017","unstructured":"Hirsch-Moverman Y, Daftary A, Yuengling KA, Saito S, Ntoane M, Frederix K, et al. Using mHealth for HIV\/TB treatment support in lesotho: enhancing Patient\u2013Provider communication in the START study. J Acquir Immune Defic Syndr. 2017;74(Suppl 1):S37. https:\/\/doi.org\/10.1097\/QAI.0000000000001202.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"25631_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219118","author":"NA Benzekri","year":"2019","unstructured":"Benzekri NA, Sambou JF, Tamba IT, Diatta JP, Sall I, Cisse O, et al. Nutrition support for HIV-TB co-infected adults in Senegal, West africa: a randomized pilot implementation study. PLoS One. 2019. https:\/\/doi.org\/10.1371\/journal.pone.0219118.","journal-title":"PLoS One"},{"issue":"9","key":"25631_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073501","volume":"8","author":"FR Kayigamba","year":"2013","unstructured":"Kayigamba FR, Bakker MI, Mugisha V, de Naeyer L, Gasana M, Cobelens F, et al. Adherence to tuberculosis treatment, sputum smear conversion and mortality: a retrospective cohort study in 48 Rwandan clinics. PLoS One. 2013;8(9):e73501. https:\/\/doi.org\/10.1371\/journal.pone.0073501.","journal-title":"PLoS One"},{"issue":"10","key":"25631_CR49","doi-asserted-by":"publisher","first-page":"e0164172","DOI":"10.1371\/journal.pone.0164172","volume":"11","author":"EO Masini","year":"2016","unstructured":"Masini EO, Mansour O, Speer CE, Addona V, Hanson CL, Sitienei JK, et al. Using survival analysis to identify risk factors for treatment interruption among new and retreatment tuberculosis patients in Kenya. PLoS One. 2016;11(10):e0164172. https:\/\/doi.org\/10.1371\/journal.pone.0164172.","journal-title":"PLoS One"},{"key":"25631_CR50","unstructured":"Stop TB. Partnership | High Burden Countries. http:\/\/www.stoptb.org\/countries\/tbdata.asp"},{"issue":"Suppl 1","key":"25631_CR51","doi-asserted-by":"publisher","first-page":"S95","DOI":"10.1097\/01.aids.0000327629.62350.59","volume":"22","author":"A Mahal","year":"2008","unstructured":"Mahal A, Canning D, Odumosu K, Okonkwo P. Assessing the economic impact of HIV\/AIDS on Nigerian households: a propensity score matching approach. AIDS. 2008;22(Suppl 1):S95\u2013101. https:\/\/doi.org\/10.1097\/01.aids.0000327629.62350.59.","journal-title":"AIDS"},{"issue":"8","key":"25631_CR52","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1080\/09540120701768446","volume":"20","author":"S Moon","year":"2008","unstructured":"Moon S, Van Leemput L, Durier N, Jambert E, Dahmane A, Jie Y, et al. Out-of-pocket costs of AIDS care in china: are free antiretroviral drugs enough? AIDS Care. 2008;20(8):984\u201394. https:\/\/doi.org\/10.1080\/09540120701768446.","journal-title":"AIDS Care"},{"issue":"9","key":"25631_CR53","doi-asserted-by":"publisher","first-page":"e0221809","DOI":"10.1371\/journal.pone.0221809","volume":"14","author":"B Banigbe","year":"2019","unstructured":"Banigbe B, Audet CM, Okonkwo P, Arije OO, Bassi E, Clouse K, et al. Effect of PEPFAR funding policy change on HIV service delivery in a large HIV care and treatment network in Nigeria. PLoS One. 2019;14(9):e0221809. https:\/\/doi.org\/10.1371\/journal.pone.0221809.","journal-title":"PLoS One"},{"issue":"1","key":"25631_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0221809","volume":"7","author":"C Ndukwe","year":"2018","unstructured":"Ndukwe C, Ibekwe P, Olakunde B, Ogungbemi K, Fatungase K, Anenih J, et al. Out-of-pocket expenditure on HIV\/AIDS services in Nigeria. Int J Health Allied Sci. 2018;7(1):1. https:\/\/doi.org\/10.1371\/journal.pone.0221809.","journal-title":"Int J Health Allied Sci"},{"issue":"1","key":"25631_CR55","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1186\/s12879-016-2054-5","volume":"16","author":"D Skinner","year":"2016","unstructured":"Skinner D, Claassens M. It\u2019s complicated: why do tuberculosis patients not initiate or stay adherent to treatment? A qualitative study from South Africa. BMC Infect Dis. 2016;16(1):712. https:\/\/doi.org\/10.1186\/s12879-016-2054-5.","journal-title":"BMC Infect Dis"},{"key":"25631_CR56","unstructured":"Diel R, Niemann S. Outcome of tuberculosis treatment in hamburg: a survey, 1997\u20132001. Volume 7. INT J TUBERC LUNG DIS; 1997."},{"issue":"6","key":"25631_CR57","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1017\/S0950268816003307","volume":"145","author":"C Nunes","year":"2017","unstructured":"Nunes C, Duarte R, Veiga AM, Taylor B. Who are the patients that default tuberculosis treatment? -. Space matters! Epidemiol Infect. 2017;145(6):1130\u20134. https:\/\/doi.org\/10.1017\/S0950268816003307.","journal-title":"Space matters! Epidemiol Infect"},{"issue":"Suppl 4","key":"25631_CR58","first-page":"S149","volume":"88","author":"S Lertmaharit","year":"2005","unstructured":"Lertmaharit S, Kamol-Ratankul P, Sawert H, Jittimanee S, Wangmanee S. Factors associated with compliance among tuberculosis patients in Thailand. J Med Assoc Thai. 2005;88(Suppl 4):S149\u201356. http:\/\/www.jmatonline.com\/PDF\/S149-S156-PB-88-S4.pdf.","journal-title":"J Med Assoc Thai"},{"issue":"4","key":"25631_CR59","doi-asserted-by":"publisher","first-page":"676","DOI":"10.5935\/1414-8145.20140096","volume":"18","author":"DC Moraes","year":"2014","unstructured":"Moraes DC, de Oliveira A, de Costa RC. Adherence of men living with HIV\/AIDS to antiretroviral treatment. Escola Anna Nery - Revista De Enfermagem. 2014;18(4):676\u201381. https:\/\/doi.org\/10.5935\/1414-8145.20140096.","journal-title":"Escola Anna Nery - Revista De Enfermagem"},{"key":"25631_CR60","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1037\/0278-6133.23.2.207","volume":"1","author":"MR DiMatteo","year":"2004","unstructured":"DiMatteo MR. Social support and patient adherence to medical treatment: A Meta-Analysis. Health Psychol. 2004;1:207\u201318. https:\/\/doi.org\/10.1037\/0278-6133.23.2.207. https:\/\/psycnet.apa.org\/doi\/.","journal-title":"Health Psychol"},{"issue":"2","key":"25631_CR61","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.hrtlng.2011.09.009","volume":"41","author":"JR Wu","year":"2012","unstructured":"Wu JR, Lennie TA, Chung ML, Frazier SK, Dekker RL, Biddle MJ, et al. Medication adherence mediates the relationship between marital status and cardiac event-free survival in patients with heart failure. Heart Lung: J Acute Crit Care. 2012;41(2):107\u201314. https:\/\/doi.org\/10.1016\/j.hrtlng.2011.09.009.","journal-title":"Heart Lung: J Acute Crit Care"},{"issue":"3","key":"25631_CR62","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1080\/00981389.2018.1563846","volume":"58","author":"AM Albanese","year":"2019","unstructured":"Albanese AM, Huffman JC, Celano CM, Malloy LM, Wexler DJ, Freedman ME, et al. The role of spousal support for dietary adherence among type 2 diabetes patients: a narrative review. Soc Work Health Care. 2019;58(3):304\u201323. https:\/\/doi.org\/10.1080\/00981389.2018.1563846.","journal-title":"Soc Work Health Care"},{"issue":"1","key":"25631_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-05545-0","volume":"7","author":"X Li","year":"2017","unstructured":"Li X, Liu Y, Wang Y, Ruan C, Wang H, Liang X, et al. The influence of marital status on survival of gallbladder cancer patients: A population-based study. Sci Rep. 2017;7(1):1\u20137. https:\/\/doi.org\/10.1038\/s41598-017-05545-0.","journal-title":"Sci Rep"},{"key":"25631_CR64","doi-asserted-by":"crossref","unstructured":"Wells C, Severn M. Incentives and support programs to improve adherence to tuberculosis treatment. CADTH Health Technol Rev. 2021:1(2). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK571645\/.","DOI":"10.51731\/cjht.2021.35"},{"key":"25631_CR65","doi-asserted-by":"publisher","DOI":"10.1080\/10400435.2016.1219884","author":"JK Schwartz","year":"2017","unstructured":"Schwartz JK. Pillbox use, satisfaction, and effectiveness among persons with chronic health conditions. Assist Technol. 2017. https:\/\/doi.org\/10.1080\/10400435.2016.1219884.","journal-title":"Assist Technol"},{"key":"25631_CR66","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/ebn.2.2.47","volume":"1","author":"C Maddock","year":"1999","unstructured":"Maddock C. Formal guidelines including a pill box improved medication adherence for patients with chronic mental illness. Evid Based Nurs. 1999;1:1. https:\/\/doi.org\/10.1136\/ebn.2.2.47.","journal-title":"Evid Based Nurs"},{"key":"25631_CR67","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00180612","author":"AS Albanna","year":"2013","unstructured":"Albanna AS, Smith BM, Cowan D, Menzies D. Fixed-dose combination antituberculosis therapy: a systematic review and meta-analysis. Eur Respir J. 2013. https:\/\/doi.org\/10.1183\/09031936.00180612.","journal-title":"Eur Respir J"},{"key":"25631_CR68","doi-asserted-by":"publisher","unstructured":"Gallardo CR, Rigau Comas D, Valderrama Rodr\u00edguez A, Roqu\u00e9 i Figuls M, Parker LA, Cayl\u00e0 J, et al. Fixed-dose combinations of drugs versus single-drug formulations for treating pulmonary tuberculosis. Cochrane Database Syst Rev. 2016;2016(5). https:\/\/doi.org\/10.1002\/14651858.CD009913.pub2.","DOI":"10.1002\/14651858.CD009913.pub2"},{"key":"25631_CR69","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2021.625078","volume":"12","author":"S Bea","year":"2021","unstructured":"Bea S, Lee H, Kim JH, Jang SH, Son H, Kwon JW, et al. Adherence and associated factors of treatment regimen in drug-susceptible tuberculosis patients. Front Pharmacol. 2021;12:1. https:\/\/doi.org\/10.3389\/fphar.2021.625078.","journal-title":"Front Pharmacol"},{"issue":"7","key":"25631_CR70","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1177\/0002764299042007004","volume":"42","author":"GM Herek","year":"1999","unstructured":"Herek GM. AIDS and stigma. Am Behav Sci. 1999;42(7):1106\u201316. https:\/\/doi.org\/10.1177\/0002764299042007004.","journal-title":"Am Behav Sci"},{"issue":"1","key":"25631_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-3704-1","volume":"19","author":"M Pantelic","year":"2019","unstructured":"Pantelic M, Sprague L, Stangl AL. It\u2019s not all in your head: critical knowledge gaps on internalized HIV stigma and a call for integrating social and structural conceptualizations. BMC Infect Dis. 2019;19(1):210. https:\/\/doi.org\/10.1186\/s12879-019-3704-1.","journal-title":"BMC Infect Dis"},{"issue":"2","key":"25631_CR72","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/1545109711432315","volume":"12","author":"WT Steward","year":"2013","unstructured":"Steward WT, Bharat S, Ramakrishna J, Heylen E, Ekstrand ML. Stigma is associated with delays in seeking care among HIV-infected people in India. J Int Assoc Provid AIDS Care. 2013;12(2):103\u20139. https:\/\/doi.org\/10.1177\/1545109711432315.","journal-title":"J Int Assoc Provid AIDS Care"},{"issue":"3","key":"25631_CR73","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/09540120600971224","volume":"19","author":"T Calin","year":"2007","unstructured":"Calin T, Green J, Hetherton J, Brook G. Disclosure of HIV among black African men and women attending a London HIV clinic. AIDS Care. 2007;19(3):385\u201391. https:\/\/doi.org\/10.1080\/09540120600971224.","journal-title":"AIDS Care"},{"issue":"3","key":"25631_CR74","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/01.mlr.0000114908.90348.f9","volume":"42","author":"MR DiMatteo","year":"2004","unstructured":"DiMatteo MR. Variations in patients\u2019 adherence to medical recommendations. Med Care. 2004;42(3):200\u20139. https:\/\/doi.org\/10.1097\/01.mlr.0000114908.90348.f9.","journal-title":"Med Care"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25631-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-25631-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25631-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T15:25:59Z","timestamp":1767626759000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12889-025-25631-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,29]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["25631"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-25631-7","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,29]]},"assertion":[{"value":"19 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ST is employed by and a shareholder of GSK. His comments and opinions are his own and not that of the company.Rest of the authors declare no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39"}}